The DOI matches its Crossref record; 322 of the 322 references it cites were found in a registry or an index.
Oxidative stress in schizophrenia: An integrated approach
Open accessAbstract
Oxidative stress has been suggested to contribute to the pathophysiology of schizophrenia. In particular, oxidative damage to lipids, proteins, and DNA as observed in schizophrenia is known to impair cell viability and function, which may subsequently account for the deteriorating course of the illness. Currently available evidence points towards an alteration in the activities of enzymatic and nonenzymatic antioxidant systems in schizophrenia. In fact, experimental models have demonstrated that oxidative stress induces behavioural and molecular anomalies strikingly similar to those observed in schizophrenia. These findings suggest that oxidative stress is intimately linked to a variety of pathophysiological processes, such as inflammation, oligodendrocyte abnormalities, mitochondrial dysfunction, hypoactive N-methyl-D-aspartate receptors and the impairment of fast-spiking gamma-aminobutyric acid interneurons.[bkyb1] Such self-sustaining mechanisms may progressively worsen producing the functional and structural consequences associated with schizophrenia. Recent clinical studies have shown antioxidant treatment to be effective in ameliorating schizophrenic symptoms. Hence, identifying viable therapeutic strategies to tackle oxidative stress and the resulting physiological disturbances provide an exciting opportunity for the treatment and ultimately prevention of schizophrenia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Free radicals in biology and medicine
(1991) · General Pharmacology: The Vascular System · doi:10.1016/0306-3623(91)90478-o · Cited by 17,178
Free radicals and antioxidants in normal physiological functions and human disease
Valko, M., Leibfritz, D., Moncol, J., Cronin, M. T. D., Mazur, M., & Telser, J. (2007) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2006.07.001 · Cited by 14,269
Neuronal Oscillations in Cortical Networks
Buzsáki, G., & Draguhn, A. (2004) · Science · doi:10.1126/science.1099745 · Cited by 6,576
Hayden, M. S., & Ghosh, S. (2004) · Genes & Development · doi:10.1101/gad.1228704 · Cited by 3,842
Implications of Normal Brain Development for the Pathogenesis of Schizophrenia
Weinberger, D. R. (1987) · Archives of General Psychiatry · doi:10.1001/archpsyc.1987.01800190080012 · Cited by 3,724
Krystal, J. H. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950030035004 · Cited by 3,330
Reactive Oxygen Species and the Central Nervous System
Halliwell, B. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb10990.x · Cited by 2,947
Recent advances in the phencyclidine model of schizophrenia
(1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.10.1301 · Cited by 2,904
Synaptic Plasticity and Memory: An Evaluation of the Hypothesis
Martin, S. J., Grimwood, P. D., & Morris, R. G. M. (2000) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.23.1.649 · Cited by 2,794
Nordberg, J., & Arnér, E. S. J. (2001) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(01)00724-9 · Cited by 2,662
Smoking and Mental Illness: A Population-Based Prevalence Study
Lasser, K., Boyd, J. W., Woolhandler, S., Himmelstein, D. U., McCormick, D., & Bor, D. H. (2000) · JAMA · doi:10.1001/jama.284.20.2606 · Cited by 2,508
Effect of COMT Val 108/158 Met genotype on frontal lobe function and risk for schizophrenia
Egan, M. F., Goldberg, T. E., Kolachana, B. S., Callicott, J. H., Mazzanti, C. M., Straub, R. E., Goldman, D., & Weinberger, D. R. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.111134598 · Cited by 2,381
Schizophrenia: A Concise Overview of Incidence, Prevalence, and Mortality
McGrath, J., Saha, S., Chant, D., & Welham, J. (2008) · Epidemiologic Reviews · doi:10.1093/epirev/mxn001 · Cited by 2,280
Radi, R., Beckman, J. S., Bush, K. M., & Freeman, B. A. (1991) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(91)90224-7 · Cited by 2,194
Kohen, R., & Nyska, A. (2002) · Toxicologic Pathology · doi:10.1080/01926230290166724 · Cited by 2,178
Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence
Harrison, P. J., & Weinberger, D. R. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001558 · Cited by 2,020
Free radical-mediated oxidation of free amino acids and amino acid residues in proteins
Stadtman, E. R., & Levine, R. L. (2003) · Amino Acids · doi:10.1007/s00726-003-0011-2 · Cited by 1,962
Gene regulation and DNA damage in the ageing human brain
Lu, T., Pan, Y., Kao, S.-Y., Li, C., Kohane, I., Chan, J., & Yankner, B. A. (2004) · Nature · doi:10.1038/nature02661 · Cited by 1,874
Jablensky, A., Sartorius, N., Ernberg, G., Anker, M., Korten, A., Cooper, J. E., Day, R., & Bertelsen, A. (1992) · Psychological Medicine. Monograph Supplement · doi:10.1017/s0264180100000904 · Cited by 1,769
Metabolism and functions of glutathione in brain
Dringen, R. (2000) · Progress in Neurobiology · doi:10.1016/s0301-0082(99)00060-x · Cited by 1,702
Diversity of structures and properties among catalases
Chelikani, P., Fita, I., & Loewen, P. C. (2004) · Cellular and Molecular Life Sciences (CMLS) · doi:10.1007/s00018-003-3206-5 · Cited by 1,700
Glutamate receptor dysfunction and schizophrenia
Olney, J. W. (1995) · Archives of General Psychiatry · doi:10.1001/archpsyc.1995.03950240016004 · Cited by 1,685
Decreased Dendritic Spine Density on Prefrontal Cortical Pyramidal Neurons in Schizophrenia
Glantz, L. A., & Lewis, D. A. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.1.65 · Cited by 1,636
Lifetime Prevalence of Psychotic and Bipolar I Disorders in a General Population
Perälä, J., Suvisaari, J., Saarni, S. I., Kuoppasalmi, K., Isometsä, E., Pirkola, S., Partonen, T., Tuulio-Henriksson, A., Hintikka, J., Kieseppä, T., et al. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.1.19 · Cited by 1,516
Toxicity of iron and hydrogen peroxide: the Fenton reaction
Winterbourn, C. C. (1995) · Toxicology Letters · doi:10.1016/0378-4274(95)03532-x · Cited by 1,415
Epigenetic regulation in psychiatric disorders
Tsankova, N., Renthal, W., Kumar, A., & Nestler, E. J. (2007) · Nature reviews. Neuroscience · doi:10.1038/nrn2132 · Cited by 1,400
Brain-state- and cell-type-specific firing of hippocampal interneurons in vivo
Klausberger, T., Magill, P. J., Márton, L. F., Roberts, J. D. B., Cobden, P. M., Buzsáki, G., & Somogyi, P. (2003) · Nature · doi:10.1038/nature01374 · Cited by 1,345
(1995) · PubMed · Cited by 1,320
Prenatal Infection and Schizophrenia: A Review of Epidemiologic and Translational Studies
Brown, A. S., & Derkits, E. J. (2010) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2009.09030361 · Cited by 1,269
Hakak, Y., Walker, J. R., Li, C., Wong, W. H., Davis, K. L., Buxbaum, J. D., Haroutunian, V., & Fienberg, A. A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.081071198 · Cited by 1,192
Berk, M., Kapczinski, F., Andreazza, A. C., Dean, O. M., Giorlando, F., Maes, M., Yücel, M., Gama, C. S., Dodd, S., Dean, B., et al. (2011) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2010.10.001 · Cited by 1,178
Schizophrenia as a Disorder of Neurodevelopment
Lewis, D. A., & Levitt, P. (2002) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.25.112701.142754 · Cited by 1,163
Oxidative stress: the paradox of aerobic life
Davies, K. J. A. (1995) · Biochemical Society Symposia · doi:10.1042/bss0610001 · Cited by 1,146
Oxidative stress in psychiatric disorders: evidence base and therapeutic implications
Ng, F., Berk, M., Dean, O., & Bush, A. I. (2008) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145707008401 · Cited by 1,069
NMDA receptor hypofunction model of schizophrenia
Olney, J. W., Newcomer, J. W., & Farber, N. B. (1999) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(99)00029-1 · Cited by 1,020
Lisman, J. E., Coyle, J. T., Green, R. W., Javitt, D. C., Benes, F. M., Heckers, S., & Grace, A. A. (2008) · Trends in Neurosciences · doi:10.1016/j.tins.2008.02.005 · Cited by 1,010
Prabakaran, S., Swatton, J. E., Ryan, M. M., Huffaker, S. J., Huang, J.-J., Griffin, J. L., Wayland, M., Freeman, T., Dudbridge, F., Lilley, K. S., et al. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001511 · Cited by 971
ROS, mitochondria and the regulation of autophagy
Scherz-Shouval, R., & Elazar, Z. (2007) · Trends in Cell Biology · doi:10.1016/j.tcb.2007.07.009 · Cited by 954
Glutamate and Schizophrenia: Beyond the Dopamine Hypothesis
Coyle, J. T. (2006) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-006-9062-8 · Cited by 917
Lucy, J. A. (1985) · FEBS Letters · doi:10.1016/0014-5793(85)80903-0 · Cited by 907
Mueser, K. T., & McGurk, S. R. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16458-1 · Cited by 876
Selemon, L. D. (1995) · Archives of General Psychiatry · doi:10.1001/archpsyc.1995.03950220015005 · Cited by 876
Superoxide‐dependent production of hydroxyl radical catalyzed by iron—EDTA complex
McCord, J. M., & Day, E. D. (1978) · FEBS Letters · doi:10.1016/0014-5793(78)80116-1 · Cited by 868
Mitochondrial damage induced by conditions of oxidative stress
Kowaltowski, A. J., & Vercesi, A. E. (1999) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(98)00216-0 · Cited by 866
Deverman, B. E., & Patterson, P. H. (2009) · Neuron · doi:10.1016/j.neuron.2009.09.002 · Cited by 865
Synaptic plasticity and dysconnection in schizophrenia
Stephan, K. E., Baldeweg, T., & Friston, K. J. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.10.005 · Cited by 841
Antioxidants, Oxidative Stress, and Degenerative Neurological Disorders
Floyd, R. A. (1999) · Proceedings of the Society for Experimental Biology and Medicine · doi:10.1046/j.1525-1373.1999.d01-140.x · Cited by 828
Sex Differences in the Risk of Schizophrenia: Evidence From Meta-analysis
Aleman, A., Kahn, R. S., & Selten, J.-P. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.6.565 · Cited by 818
Lewis, D. A., & Lieberman, J. A. (2000) · Neuron · doi:10.1016/s0896-6273(00)00111-2 · Cited by 811
Microglial cell cytotoxicity of oligodendrocytes is mediated through nitric oxide.
Merrill, J. E., Ignarro, L. J., Sherman, M. P., Melinek, J., & Lane, T. E. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.4.2132 · Cited by 781
Immune involvement in schizophrenia and autism: Etiology, pathology and animal models
Patterson, P. H. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.12.016 · Cited by 766
Cai, J., & Jones, D. P. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.19.11401 · Cited by 765
Sex differences in schizophrenia, a review of the literature
Leung M.D., D. A., & Chue M. R. C. Psych., D. P. (2000) · Acta Psychiatrica Scandinavica · doi:10.1111/j.0065-1591.2000.0ap25.x · Cited by 748
New Insights into the Mechanism of Action of Amphetamines
Fleckenstein, A. E., Volz, T. J., Riddle, E. L., Gibb, J. W., & Hanson, G. R. (2007) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.47.120505.105140 · Cited by 731
Cigarette smoking: implications for psychiatric illness
(1993) · American Journal of Psychiatry · doi:10.1176/ajp.150.4.546 · Cited by 723
Reduced dendritic spine density on cerebral cortical pyramidal neurons in schizophrenia
Garey, L. J., Ong, W. Y., Patel, T. S., Kanani, M., Davis, A., Mortimer, A. M., Barnes, T. R. E., & Hirsch, S. R. (1998) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.65.4.446 · Cited by 718
Bains, J. S., & Shaw, C. A. (1997) · Brain Research Reviews · doi:10.1016/s0165-0173(97)00045-3 · Cited by 717
Redox regulation of transcriptional activators
Sun, Y., & Oberley, L. W. (1996) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(96)00109-8 · Cited by 692
Akbarian, S. (1993) · Archives of General Psychiatry · doi:10.1001/archpsyc.1993.01820150007001 · Cited by 678
Homocyst(e)ine Decreases Bioavailable Nitric Oxide by a Mechanism Involving Glutathione Peroxidase
Upchurch, G. R., Welch, G. N., Fabian, A. J., Freedman, J. E., Johnson, J. L., Keaney, J. F., & Loscalzo, J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.27.17012 · Cited by 668
Javitt, D. C., Steinschneider, M., Schroeder, C. E., & Arezzo, J. C. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.21.11962 · Cited by 662
Uranova, N. A., Vostrikov, V. M., Orlovskaya, D. D., & Rachmanova, V. I. (2004) · Schizophrenia Research · doi:10.1016/s0920-9964(03)00181-6 · Cited by 659
Chauhan, A., & Chauhan, V. (2006) · Pathophysiology · doi:10.1016/j.pathophys.2006.05.007 · Cited by 656
Freund, T. F., & Katona, I. (2007) · Neuron · doi:10.1016/j.neuron.2007.09.012 · Cited by 656
Interneuron Diversity series: Rhythm and mood in perisomatic inhibition
Freund, T. F. (2003) · Trends in Neurosciences · doi:10.1016/s0166-2236(03)00227-3 · Cited by 641
Schizophrenia: Diverse Approaches to a Complex Disease
Sawa, A., & Snyder, S. H. (2002) · Science · doi:10.1126/science.1070532 · Cited by 597
Gawryluk, J. W., Wang, J.-F., Andreazza, A. C., Shao, L., & Young, L. T. (2011) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145710000805 · Cited by 594
Back, S. A., Gan, X., Li, Y., Rosenberg, P. A., & Volpe, J. J. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-16-06241.1998 · Cited by 586
Ketamine-Induced Loss of Phenotype of Fast-Spiking Interneurons Is Mediated by NADPH-Oxidase
Behrens, M. M., Ali, S. S., Dao, D. N., Lucero, J., Shekhtman, G., Quick, K. L., & Dugan, L. L. (2007) · Science · doi:10.1126/science.1148045 · Cited by 585
Lenaz, G. (2001) · IUBMB Life · doi:10.1080/15216540152845957 · Cited by 585
Umbricht, D., Schmid, L., Koller, R., Vollenweider, F. X., Hell, D., & Javitt, D. C. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.12.1139 · Cited by 583
Cigarette smoking in schizophrenia: relationship to psychopathology and medication side effects
(1992) · American Journal of Psychiatry · doi:10.1176/ajp.149.9.1189 · Cited by 579
The Glutamatergic Dysfunction Hypothesis for Schizophrenia
Coyle, J. T. (1996) · Harvard Review of Psychiatry · doi:10.3109/10673229609017192 · Cited by 568
Pakkenberg, B. (1990) · Archives of General Psychiatry · doi:10.1001/archpsyc.1990.01810230039007 · Cited by 564
Copper and iron disorders of the brain
Madsen, E., & Gitlin, J. D. (2007) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.30.051606.094232 · Cited by 557
Berk, M., Copolov, D., Dean, O., Lu, K., Jeavons, S., Schapkaitz, I., Anderson-Hunt, M., Judd, F., Katz, F., Katz, P., et al. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.03.004 · Cited by 552
Schizophrenia: glutathione deficit in cerebrospinal fluid and prefrontal cortex in vivo
Do, K. Q., Trabesinger, A. H., Kirsten‐Krüger, M., Lauer, C. J., Dydak, U., Hell, D., Holsboer, F., Boesiger, P., & Cuénod, M. (2000) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2000.00229.x · Cited by 540
Prenatal Infection as a Risk Factor for Schizophrenia
Brown, A. S. (2006) · Schizophrenia Bulletin · doi:10.1093/schbul/sbj052 · Cited by 539
Vulnerability of oligodendroglia to glutamate: pharmacology, mechanisms, and prevention
Oka, A., Belliveau, M., Rosenberg, P., & Volpe, J. (1993) · The Journal of Neuroscience · doi:10.1523/jneurosci.13-04-01441.1993 · Cited by 504
Interneuron Diversity series: Inhibitory interneurons and network oscillations in vitro
Whittington, M. A., & Traub, R. D. (2003) · Trends in Neurosciences · doi:10.1016/j.tins.2003.09.016 · Cited by 501
Mustafa, A. K., Gadalla, M. M., & Snyder, S. H. (2009) · Science Signaling · doi:10.1126/scisignal.268re2 · Cited by 496
Heinecke, J. W., Rosen, H., Suzuki, L. A., & Chait, A. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)61082-8 · Cited by 460
Akbarian, S. (1993) · Archives of General Psychiatry · doi:10.1001/archpsyc.1993.01820150016002 · Cited by 456
Peroxide detoxification by brain cells
Dringen, R., Pawlowski, P. G., & Hirrlinger, J. (2005) · Journal of Neuroscience Research · doi:10.1002/jnr.20280 · Cited by 451
Andreazza, A. C., Shao, L., Wang, J.-F., & Young, L. T. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.22 · Cited by 448
Nitric oxide as an antioxidant
Kanner, J., Harel, S., & Rina, G. (1991) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(91)90452-o · Cited by 429
N -acetylcysteine for antioxidant therapy: pharmacology and clinical utility
Dodd, S., Dean, O., Copolov, D. L., Malhi, G. S., & Berk, M. (2008) · Expert Opinion on Biological Therapy · doi:10.1517/14728220802517901 · Cited by 413
Normalization by nicotine of deficient auditory sensory gating in the relatives of schizophrenics
Adler, L. E., Hoffer, L. J., Griffith, J., Waldo, M. C., & Freedman, R. (1992) · Biological Psychiatry · doi:10.1016/0006-3223(92)90073-9 · Cited by 412
Mismatch negativity: An index of a preattentive processing deficit in schizophrenia
Shelley, A. M., Ward, P. B., Catts, S. V., Michie, P. T., Andrews, S., & McConaghy, N. (1991) · Biological Psychiatry · doi:10.1016/0006-3223(91)90126-7 · Cited by 411
Woo, T.-U. W., Walsh, J. P., & Benes, F. M. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.7.649 · Cited by 411
Self-citationIron and Oxidative Stress in Pregnancy
Casanueva, E., & Viteri, F. E. (2003) · The Journal of Nutrition · doi:10.1093/jn/133.5.1700s · Cited by 408
Mismatch Negativity Deficits Are Associated With Poor Functioning in Schizophrenia Patients
Light, G. A., & Braff, D. L. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.2.127 · Cited by 407
Ranjekar, P. K., Hinge, A., Hegde, M. V., Ghate, M., Kale, A., Sitasawad, S., Wagh, U. V., Debsikdar, V. B., & Mahadik, S. P. (2003) · Psychiatry Research · doi:10.1016/s0165-1781(03)00220-8 · Cited by 395
Fallin, M. D., Lasseter, V. K., Avramopoulos, D., Nicodemus, K. K., Wolyniec, P. S., McGrath, J. A., Steel, G., Nestadt, G., Liang, K.-Y., Huganir, R. L., et al. (2005) · The American Journal of Human Genetics · doi:10.1086/497703 · Cited by 395
Selemon, L. D., Rajkowska, G., & Goldman-Rakic, P. S. (1998) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19980316)392:3<402::aid-cne9>3.0.co;2-5 · Cited by 393
Redox dysregulation, neurodevelopment, and schizophrenia
Do, K. Q., Cabungcal, J. H., Frank, A., Steullet, P., & Cuenod, M. (2009) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2009.05.001 · Cited by 384
Cysteine regulation of protein function – as exemplified by NMDA-receptor modulation
Lipton, S. A., Choi, Y.-B., Takahashi, H., Zhang, D., Li, W., Godzik, A., & Bankston, L. A. (2002) · Trends in Neurosciences · doi:10.1016/s0166-2236(02)02245-2 · Cited by 375
Prabakaran, S., Swatton, J. E., Ryan, M. M., Huffaker, S. J., Huang, J. T.-J., Griffin, J. L., Wayland, M., Freeman, T., Dudbridge, F., Lilley, K. S., et al. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001532 · Cited by 375
Glutathione Precursor, N-Acetyl-Cysteine, Improves Mismatch Negativity in Schizophrenia Patients
Lavoie, S., Murray, M. M., Deppen, P., Knyazeva, M. G., Berk, M., Boulat, O., Bovet, P., Bush, A. I., Conus, P., Copolov, D., et al. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301624 · Cited by 371
Li, J., Baud, O., Vartanian, T., Volpe, J. J., & Rosenberg, P. A. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0502552102 · Cited by 370
James, S. J., Melnyk, S., Pogribna, M., Pogribny, I. P., & Caudill, M. A. (2002) · The Journal of Nutrition · doi:10.1093/jn/132.8.2361s · Cited by 367
Brain potential evidence for an auditory sensory memory deficit in schizophrenia
(1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.2.213 · Cited by 360
Enzymatic Oxidation of Dopamine: The Role of Prostaglandin H Synthase
Hastings, T. G. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.64020919.x · Cited by 359
Keller, J. N., Mark, R. J., Bruce, A. J., Blanc, E., Rothstein, J. D., Uchida, K., Waeg, G., & Mattson, M. P. (1997) · Neuroscience · doi:10.1016/s0306-4522(97)00065-1 · Cited by 357
Humphries, K. M., & Szweda, L. I. (1998) · Biochemistry · doi:10.1021/bi981512h · Cited by 355
Do event-related potentials reveal the mechanism of the auditory sensory memory in the human brain?
Näätänen, R., Paavilainen, P., Alho, K., Reinikainen, K., & Sams, M. (1989) · Neuroscience Letters · doi:10.1016/0304-3940(89)90513-2 · Cited by 350
Lipid Peroxidation and Mechanisms of Toxicity
Horton, A. A., Fairhurst, S., & Bus, J. S. (1987) · CRC Critical Reviews in Toxicology · doi:10.3109/10408448709089856 · Cited by 339
Roles of NMDA receptor activity and nitric oxide production in brain development
Contestabile, A. (2000) · Brain Research Reviews · doi:10.1016/s0165-0173(00)00018-7 · Cited by 338
Transferrin and Iron in Normal, Alzheimer's Disease, and Parkinson's Disease Brain Regions
Loeffler, D. A., Connor, J. R., Juneau, P. L., Snyder, B. S., Kanaley, L., DeMaggio, A. J., Nguyen, H., Brickman, C. M., & LeWitt, P. A. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.65020710.x · Cited by 334
Kinney, J. W., Davis, C. N., Tabarean, I., Conti, B., Bartfai, T., & Behrens, M. M. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.4722-05.2006 · Cited by 329
BENSON, D. F. (1992) · American Journal of Psychiatry · doi:10.1176/ajp.149.10.1400-a · Cited by 329
Excitatory amino acids and neuropsychiatrie disorders
Olney, J. W. (1989) · Biological Psychiatry · doi:10.1016/0006-3223(89)90072-3 · Cited by 322
Altered glutathione redox state in schizophrenia.
Yao, J. K., Leonard, S., & Reddy, R. (2006) · Disease Markers · doi:10.1155/2006/248387 · Cited by 321
Lipid peroxidation and antioxidant enzyme levels in patients with schizophrenia and bipolar disorder
Kuloglu, M., Ustundag, B., Atmaca, M., Canatan, H., Tezcan, A. E., & Cinkilinc, N. (2002) · Cell Biochemistry and Function · doi:10.1002/cbf.940 · Cited by 321
Maternal Cytokine Levels during Pregnancy and Adult Psychosis
Buka, S. L., Tsuang, M. T., Torrey, E. F., Klebanoff, M. A., Wagner, R. L., & Yolken, R. H. (2001) · Brain, Behavior, and Immunity · doi:10.1006/brbi.2001.0644 · Cited by 321
A Review of the Fetal Brain Cytokine Imbalance Hypothesis of Schizophrenia
Meyer, U., Feldon, J., & Yee, B. K. (2009) · Schizophrenia Bulletin · doi:10.1093/schbul/sbn022 · Cited by 320
Jaaro-Peled, H., Hayashi-Takagi, A., Seshadri, S., Kamiya, A., Brandon, N. J., & Sawa, A. (2009) · Trends in Neurosciences · doi:10.1016/j.tins.2009.05.007 · Cited by 319
Schizophrenia: the fundamental questions
Andreasen, N. (2000) · Brain Research Reviews · doi:10.1016/s0165-0173(99)00027-2 · Cited by 312
Impaired glutathione synthesis in schizophrenia: Convergent genetic and functional evidence
Gysin, R., Kraftsik, R., Sandell, J., Bovet, P., Chappuis, C., Conus, P., Deppen, P., Preisig, M., Ruiz, V., Steullet, P., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706778104 · Cited by 309
New Techniques for Biopsy and Culture of Human Olfactory Epithelial Neurons
Féron, F., Perry, C., McGrath, J. J., & Mackay-Sim, A. (1998) · Archives of Otolaryngology–Head & Neck Surgery · doi:10.1001/archotol.124.8.861 · Cited by 305
Synaptic signaling by nitric oxide
Brenman, J. E., & Bredt, D. S. (1997) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(97)80065-7 · Cited by 301
Selective vulnerability in the developing central nervous system
McQuillen, P. S., & Ferriero, D. M. (2004) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2003.10.001 · Cited by 287
Mitochondrial matrix reactive oxygen species production is very sensitive to mild uncoupling
Miwa, S., & Brand, M. D. (2003) · Biochemical Society Transactions · doi:10.1042/bst0311300 · Cited by 285
Oxidative Damage and Schizophrenia: An Overview of the Evidence and Its Therapeutic Implications
Yao, J. K., Reddy, R. D., & van Kammen, D. P. (2001) · CNS Drugs · doi:10.2165/00023210-200115040-00004 · Cited by 280
Arvindakshan, M. (2003) · Schizophrenia Research · doi:10.1016/s0920-9964(02)00284-0 · Cited by 280
Carroll, B. J., & Barrett, J. E. (1991) · Medical Entomology and Zoology · Cited by 279
Factors contributing to the outcome of oxidative damage to nucleic acids
Evans, M. D., & Cooke, M. S. (2004) · BioEssays · doi:10.1002/bies.20027 · Cited by 279
Nitric oxide induces neurotransmitter release from hippocampal slices
Lonart, G., Wang, J., & Johnson, K. M. (1992) · European Journal of Pharmacology · doi:10.1016/0014-2999(92)90759-w · Cited by 270
Initial Characterization of the Glutamate-Cysteine Ligase Modifier Subunit Gclm(−/−) Knockout Mouse
Yang, Y., Dieter, M. Z., Chen, Y., Shertzer, H. G., Nebert, D. W., & Dalton, T. P. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m209372200 · Cited by 269
An update on the role of free radicals and antioxidant defense in human disease
Vendemiale, G., Grattagliano, I., & Altomare, E. (1999) · International Journal of Clinical & Laboratory Research · doi:10.1007/s005990050063 · Cited by 269
Calabrese, V., Scapagnini, G., Giuffrida Stella, A. M., Bates, T. E., & Clark, J. B. (2001) · Neurochemical Research · doi:10.1023/a:1010955807739 · Cited by 263
Zhang, X. Y., Tan, Y. L., Cao, L. Y., Wu, G. Y., Xu, Q., Shen, Y., & Zhou, D. F. (2006) · Schizophrenia Research · doi:10.1016/j.schres.2005.10.011 · Cited by 262
Phenotype of schizophrenia: a review and formulation
Tamminga, C. A., & Holcomb, H. H. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001563 · Cited by 262
In utero infection and adult schizophrenia
Brown, A. S., & Susser, E. S. (2002) · Mental Retardation and Developmental Disabilities Research Reviews · doi:10.1002/mrdd.10004 · Cited by 261
Alterations of cortical GABA neurons and network oscillations in schizophrenia
Gonzalez-Burgos, G., Hashimoto, T., & Lewis, D. A. (2010) · Current Psychiatry Reports · doi:10.1007/s11920-010-0124-8 · Cited by 260
Beneyto, M., & Meador-Woodruff, J. H. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301604 · Cited by 259
NMDA receptor channels: Subunit-specific potentiation by reducing agents
Köhr, G., Eckardt, S., Lüddens, H., Monyer, H., & Seeburg, P. H. (1994) · Neuron · doi:10.1016/0896-6273(94)90311-5 · Cited by 257
Wright, R. O., & Baccarelli, A. (2007) · The Journal of Nutrition · doi:10.1093/jn/137.12.2809 · Cited by 257
Antioxidants as treatment for neurodegenerative disorders
Moosmann, B., & Behl, C. (2002) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.11.10.1407 · Cited by 252
Olincy, A., Young, D. A., & Freedman, R. (1997) · Biological Psychiatry · doi:10.1016/s0006-3223(96)00302-2 · Cited by 252
Subnucleus-specific loss of neurons in medial thalamus of schizophrenics
Popken, G. J., Bunney, W. E., Potkin, S. G., & Jones, E. G. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.150243397 · Cited by 250
The role of glutamate in central nervous system health and disease – A review
Platt, S. R. (2007) · The Veterinary Journal · doi:10.1016/j.tvjl.2005.11.007 · Cited by 245
Kunz, M., Gama, C. S., Andreazza, A. C., Salvador, M., Ceresér, K. M., Gomes, F. A., Belmonte-de-Abreu, P. S., Berk, M., & Kapczinski, F. (2008) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2008.07.001 · Cited by 242
Interleukin-6 Mediates the Increase in NADPH-Oxidase in the Ketamine Model of Schizophrenia
Behrens, M. M., Ali, S. S., & Dugan, L. L. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.4457-08.2008 · Cited by 241
Javitt, D. C., Grochowski, S., Shelley, A.-M., & Ritter, W. (1998) · Electroencephalography and Clinical Neurophysiology/Evoked Potentials Section · doi:10.1016/s0168-5597(97)00073-7 · Cited by 241
NMDA receptor regulation of memory and behavior in humans
Newcomer, J. W., & Krystal, J. H. (2001) · Hippocampus · doi:10.1002/hipo.1069 · Cited by 241
Herken, H., Uz, E., Özyurt, H., Söğüt, S., Virit, O., & Akyol, Ö. (2001) · Molecular Psychiatry · doi:10.1038/sj.mp.4000789 · Cited by 238
Javitt, D. C., Doneshka, P., Zylberman, I., Ritter, W., & Vaughan, H. G. (1993) · Biological Psychiatry · doi:10.1016/0006-3223(93)90005-x · Cited by 236
Schizophrenia and Oxidative Stress: Glutamate Cysteine Ligase Modifier as a Susceptibility Gene
Tosic, M., Ott, J., Barral, S., Bovet, P., Deppen, P., Gheorghita, F., Matthey, M.-L., Parnas, J., Preisig, M., Saraga, M., et al. (2006) · The American Journal of Human Genetics · doi:10.1086/507566 · Cited by 234
Bernstein, H.-G., Stanarius, A., Baumann, B., Henning, H., Krell, D., Danos, P., Falkai, P., & Bogerts, B. (1998) · Neuroscience · doi:10.1016/s0306-4522(97)00461-2 · Cited by 223
Mitochondrial dysfunction in schizophrenia: a possible linkage to dopamine
Ben‐Shachar, D. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01263.x · Cited by 222
Berg, D., Youdim, M. B. H., & Riederer, P. (2004) · Cell and Tissue Research · doi:10.1007/s00441-004-0976-5 · Cited by 220
Epigenetics in the Nervous System: Figure 1.
Jiang, Y., Langley, B., Lubin, F. D., Renthal, W., Wood, M. A., Yasui, D. H., Kumar, A., Nestler, E. J., Akbarian, S., & Beckel-Mitchener, A. C. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.3797-08.2008 · Cited by 214
Reif, A., Herterich, S., Strobel, A., Ehlis, A.-C., Saur, D., Jacob, C. P., Wienker, T., Töpner, T., Fritzen, S., Walter, U., et al. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001779 · Cited by 210
Exposure to infection and brain development: cytokines in the pathogenesis of schizophrenia
GILMORE, J., & FREDRIKJARSKOG, L. (1997) · Schizophrenia Research · doi:10.1016/s0920-9964(96)00123-5 · Cited by 209
Mitochondrial complex i subunits expression is altered in schizophrenia: a postmortem study
Karry, R., Klein, E., & Ben Shachar, D. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2003.12.012 · Cited by 208
Ferritin: a novel mechanism for delivery of iron to the brain and other organs
Fisher, J., Devraj, K., Ingram, J., Slagle-Webb, B., Madhankumar, A. B., Liu, X., Klinger, M., Simpson, I. A., & Connor, J. R. (2007) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00599.2006 · Cited by 206
Cytokine hypothesis of schizophrenia pathogenesis: Evidence from human studies and animal models
Watanabe, Y., Someya, T., & Nawa, H. (2010) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.2010.02094.x · Cited by 203
Steullet, P., Cabungcal, J.-H., Kulak, A., Kraftsik, R., Chen, Y., Dalton, T. P., Cuenod, M., & Do, K. Q. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.3857-09.2010 · Cited by 202
Matsuzawa, D., Obata, T., Shirayama, Y., Nonaka, H., Kanazawa, Y., Yoshitome, E., Takanashi, J., Matsuda, T., Shimizu, E., Ikehira, H., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001944 · Cited by 201
Free radical pathology in schizophrenia: a review
Reddy, R. D., & Yao, J. K. (1996) · Prostaglandins, Leukotrienes and Essential Fatty Acids · doi:10.1016/s0952-3278(96)90143-x · Cited by 201
Nitric oxide increases dopamine and serotonin release in the medial preoptic area
Lorrain, D. S., & Hull, E. M. (1993) · NeuroReport · doi:10.1097/00001756-199310000-00024 · Cited by 200
Maternal Iron Deficiency and the Risk of Schizophrenia in Offspring
Insel, B. J., Schaefer, C. A., McKeague, I. W., Susser, E. S., & Brown, A. S. (2008) · Archives of General Psychiatry · doi:10.1001/archpsyc.65.10.1136 · Cited by 199
Disease-specific, neurosphere-derived cells as models for brain disorders
Matigian, N., Abrahamsen, G., Sutharsan, R., Cook, A. L., Vitale, A. M., Nouwens, A., Bellette, B., An, J., Anderson, M., Beckhouse, A. G., et al. (2010) · Disease Models & Mechanisms · doi:10.1242/dmm.005447 · Cited by 198
Peroxide-scavenging deficit underlies oligodendrocyte susceptibility to oxidative stress
Juurlink, B. H. J., Thorburne, S. K., & Hertz, L. (1998) · Glia · doi:10.1002/(sici)1098-1136(199804)22:4<371::aid-glia6>3.0.co;2-6 · Cited by 196
Reduced plasma antioxidants in first-episode patients with schizophrenia
Reddy, R. (2003) · Schizophrenia Research · doi:10.1016/s0920-9964(02)00407-3 · Cited by 194
Mitochondria, Synaptic Plasticity, And Schizophrenia
Ben-Shachar, D., & Laifenfeld, D. (2004) · International Review of Neurobiology · doi:10.1016/s0074-7742(04)59011-6 · Cited by 193
Hydrogen Peroxide Modulation of Synaptic Plasticity
Kamsler, A., & Segal, M. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-01-00269.2003 · Cited by 188
Schizophrenia: breakdown in the well-regulated lifelong process of brain development and maturation
Bartzokis, G. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(02)00364-0 · Cited by 179
Mitochondrial Production of Oxygen Radical Species and the Role of Coenzyme Q as an Antioxidant
Genova, M. L., Pich, M. M., Biondi, A., Bernacchia, A., Falasca, A. I., Bovina, C., Formiggini, G., Castelli, G. P., & Lenaz, G. (2003) · Experimental Biology and Medicine · doi:10.1177/15353702-0322805-14 · Cited by 177
The role of oligodendrocyte pathology in schizophrenia
Uranova, N. A., Vostrikov, V. M., Vikhreva, O. V., Zimina, I. S., Kolomeets, N. S., & Orlovskaya, D. D. (2007) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145707007626 · Cited by 176
Calcium signaling dysfunction in schizophrenia: a unifying approach
Lidow, M. S. (2003) · Brain Research Reviews · doi:10.1016/s0165-0173(03)00203-0 · Cited by 175
Hindley, S., Juurlink, B. H. J., Gysbers, J. W., Middlemiss, P. J., Herman, M. A. R., & Rathbone, M. P. (1997) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19970215)47:4<427::aid-jnr8>3.0.co;2-g · Cited by 174
Steullet, P., Neijt, H. C., Cuénod, M., & Do, K. Q. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2005.10.014 · Cited by 173
A meta-analysis of oxidative stress markers in schizophrenia
Zhang, M., Zhao, Z., He, L., & Wan, C. (2010) · Science China Life Sciences · doi:10.1007/s11427-010-0013-8 · Cited by 173
Raffa, M., Mechri, A., Othman, L. B., Fendri, C., Gaha, L., & Kerkeni, A. (2009) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2009.06.018 · Cited by 173
Epigenetic mechanisms in the context of complex diseases
van Vliet, J., Oates, N. A., & Whitelaw, E. (2007) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-6526-z · Cited by 173
Padurariu, M., Ciobica, A., Dobrin, I., & Stefanescu, C. (2010) · Neuroscience Letters · doi:10.1016/j.neulet.2010.05.088 · Cited by 171
Schizophrenia and viral infection during neurodevelopment: a focus on mechanisms
Pearce, B. D. (2001) · Molecular Psychiatry · doi:10.1038/sj.mp.4000956 · Cited by 171
Elevated Prenatal Homocysteine Levels as a Risk Factor for Schizophrenia
Brown, A. S., Bottiglieri, T., Schaefer, C. A., Quesenberry, C. P., Liu, L., Bresnahan, M. A., & Susser, E. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.1.31 · Cited by 169
Both Iron Deficiency and Daily Iron Supplements Increase Lipid Peroxidation in Rats
Knutson, M. D., Walter, P. B., Ames, B. N., & Viteri, F. E. (2000) · The Journal of Nutrition · doi:10.1093/jn/130.3.621 · Cited by 168
Dugan, L. L., Ali, S. S., Shekhtman, G., Roberts, A. J., Lucero, J., Quick, K. L., & Behrens, M. M. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005518 · Cited by 165
Redox modulation of the NMDA receptor
Choi, Y.-B., & Lipton, S. A. (2000) · Cellular and Molecular Life Sciences CMLS · doi:10.1007/pl00000638 · Cited by 165
Enzymes of the antioxidant defense system in chronic schizophrenic patients
Reddy, R. D., Mahadik, S. P., Mukherjee, S., & Murthy, J. N. (1991) · Biological Psychiatry · doi:10.1016/0006-3223(91)90298-z · Cited by 165
Elevated Plasma Lipid Peroxides at the Onset of Nonaffective Psychosis
Mahadik, S. P., Mukherjee, S., Scheffer, R., Correnti, E. E., & Mahadik, J. S. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(97)00282-5 · Cited by 163
Brzustowicz, L. M., Simone, J., Mohseni, P., Hayter, J. E., Hodgkinson, K. A., Chow, E. W. C., & Bassett, A. S. (2004) · The American Journal of Human Genetics · doi:10.1086/420774 · Cited by 163
Behrens, M. M., & Sejnowski, T. J. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.06.002 · Cited by 162
Reduced status of plasma total antioxidant capacity in schizophrenia
Yao, J. K., Reddy, R., McElhinny, L. G., & van Kammen, D. P. (1998) · Schizophrenia Research · doi:10.1016/s0920-9964(98)00030-9 · Cited by 161
Impaired antioxidant defense at the onset of psychosis
Mukherjee, S., Mahadik, S. P., Scheffer, R., Correnti, E. E., & Kelkar, H. (1996) · Schizophrenia Research · doi:10.1016/0920-9964(95)00048-8 · Cited by 161
An inhibitor of nitric oxide synthesis prevents memory formation in the chick
Hölscher, C., & Rose, S. P. R. (1992) · Neuroscience Letters · doi:10.1016/0304-3940(92)90012-v · Cited by 160
Focal white matter density changes in schizophrenia: reduced inter-hemispheric connectivity
Hulshoff Pol, H. E., Schnack, H. G., Mandl, R. C. W., Cahn, W., Collins, D. L., Evans, A. C., & Kahn, R. S. (2004) · NeuroImage · doi:10.1016/j.neuroimage.2003.09.026 · Cited by 159
Early and late environmental risk factors for schizophrenia
McDonald, C. (2000) · Brain Research Reviews · doi:10.1016/s0165-0173(99)00030-2 · Cited by 158
Dopamine-induced oxidative stress in neurons with glutathione deficit: implication for schizophrenia
Grima, G., Benz, B., Parpura, V., Cuénod, M., & Do, K. Q. (2003) · Schizophrenia Research · doi:10.1016/s0920-9964(02)00405-x · Cited by 156
Antioxidant Therapy in Neurologic Disease
Delanty, N., & Dichter, M. A. (2000) · Archives of Neurology · doi:10.1001/archneur.57.9.1265 · Cited by 155
Martins‐de‐Souza, D., Gattaz, W. F., Schmitt, A., Novello, J. C., Marangoni, S., Turck, C. W., & Dias‐Neto, E. (2009) · BMC Psychiatry · doi:10.1186/1471-244x-9-17 · Cited by 153
Buntinx, M., Moreels, M., Vandenabeele, F., Lambrichts, I., Raus, J., Steels, P., Stinissen, P., & Ameloot, M. M. (2004) · Journal of Neuroscience Research · doi:10.1002/jnr.20118 · Cited by 153
Regulation of Neuronal Proliferation and Differentiation by Nitric Oxide
Gibbs, S. M. (2003) · Molecular Neurobiology · doi:10.1385/mn:27:2:107 · Cited by 152
Sex Differences in Brain Morphology in Schizophrenia
Nopoulos, P., Flaum, M. A., & Andreasen, N. C. (1997) · American Journal of Psychiatry · doi:10.1176/ajp.154.12.1648 · Cited by 152
Paşca, S. P., Nemeş, B., Vlase, L., Gagyi, C. E., Dronca, E., Miu, A. C., & Dronca, M. (2006) · Life Sciences · doi:10.1016/j.lfs.2005.09.040 · Cited by 151
Smoking and Malignancy in Schizophrenia
Masterson, E. L., & O’Shea, B. (1984) · The British Journal of Psychiatry · doi:10.1192/bjp.145.4.429 · Cited by 151
Cited by
Role of oxidative stress in depression
Bhatt, S., Nagappa, A. N., & Patil, C. R. (2020) · Drug Discovery Today · doi:10.1016/j.drudis.2020.05.001 · Cited by 821
Meta-analysis of oxidative stress in schizophrenia.
Flatow, J., Buckley, P., & Miller, B. J. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.03.018 · Cited by 491
Free radicals, antioxidant defense systems, and schizophrenia
Wu, J. Q., Kosten, T. R., & Zhang, X. Y. (2013) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2013.02.015 · Cited by 424
A Brief Overview on Antioxidant Activity Determination of Silver Nanoparticles
Bedlovičová, Z., Strapáč, I., Baláž, M., & Salayová, A. (2020) · Molecules · doi:10.3390/molecules25143191 · Cited by 387
Clusterin in Alzheimer’s Disease: Mechanisms, Genetics, and Lessons From Other Pathologies
Foster, E. M., Dangla-Valls, A., Lovestone, S., Ribe, E. M., & Buckley, N. J. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00164 · Cited by 381
Metadata
- Authors
- Bitanihirwe, B. K. Y., & Woo, T.-U. W.
- Venue
- Neuroscience & Biobehavioral Reviews
- Publisher
- Elsevier BV
- Published
- 2011-01
- Volume
- 35
- Issue
- 3
- Pages
- 878-893
- ISSN
- 0149-7634 (ISSN-L)
- OpenAlex
- W1965707086
- Cited by
- 472
- References
- 322
- FWCI
- 14.75
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.